Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × Immune Checkpoint Inhibitors × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Squamous Cell Carcinoma of Head and Neck 4 Melanoma 4 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Solid Cancers 2 Rectal Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Breast Neoplasms 2 Turcot syndrome 1 Stomach Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Skin Neoplasms 1 Sarcopenia 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma 1 SCLC 1 Rhabdomyosarcoma 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neoadjuvant Therapies 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1

Interventions

Cisplatin 8 Pemetrexed 7 Carboplatin 4 Platinum 3 Nivolumab 3 Ipilimumab 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 pembrolizumab 2 durvalumab 2 Cyclophosphamide 2 methoxyamine 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 cediranib 1 bintrafusp alfa protein, human 1 atezolizumab 1 aldesleukin 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Pharmaceutical Preparations 1 Interleukin-2 1 In Situ Hybridization, Fluorescence 1 Imprint II 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡